- Home
- IAS vs LGND Comparison
IAS vs LGND Comparison
Compare IAS & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IAS
- LGND
- Stock Information
- Founded
- IAS 2009
- LGND 1987
- Country
- IAS United States
- LGND United States
- Employees
- IAS N/A
- LGND N/A
- Industry
- IAS Computer Software: Programming Data Processing
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- IAS Technology
- LGND Health Care
- Exchange
- IAS Nasdaq
- LGND Nasdaq
- Market Cap
- IAS 1.0B
- LGND 2.1B
- IPO Year
- IAS 2021
- LGND 1992
- Fundamental
- Price
- IAS $7.79
- LGND $102.51
- Analyst Decision
- IAS Buy
- LGND Strong Buy
- Analyst Count
- IAS 11
- LGND 7
- Target Price
- IAS $13.15
- LGND $144.67
- AVG Volume (30 Days)
- IAS 855.6K
- LGND 100.4K
- Earning Date
- IAS 05-12-2025
- LGND 05-08-2025
- Dividend Yield
- IAS N/A
- LGND N/A
- EPS Growth
- IAS 475.01
- LGND N/A
- EPS
- IAS 0.23
- LGND N/A
- Revenue
- IAS $530,101,000.00
- LGND $181,488,000.00
- Revenue This Year
- IAS $13.03
- LGND $16.47
- Revenue Next Year
- IAS $11.76
- LGND $19.44
- P/E Ratio
- IAS $33.96
- LGND N/A
- Revenue Growth
- IAS 11.75
- LGND 53.40
- 52 Week Low
- IAS $6.26
- LGND $72.61
- 52 Week High
- IAS $13.62
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- IAS 58.91
- LGND 42.08
- Support Level
- IAS $6.97
- LGND $102.50
- Resistance Level
- IAS $7.33
- LGND $111.42
- Average True Range (ATR)
- IAS 0.24
- LGND 3.87
- MACD
- IAS 0.18
- LGND -0.31
- Stochastic Oscillator
- IAS 93.00
- LGND 24.59
About IAS Integral Ad Science Holding Corp.
Integral Ad Science Holding Corp is a digital advertising verification company. The cloud-based technology platform of the company delivers independent measurement and verification of digital advertising across all devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video. Geographically, the company derives a majority of its revenue from the Americas region.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.